Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.71 -0.48 (-1.89%)
Official Closing Price Updated: 4:15 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Moderna's Options: A Look at What the Big Money is Thinking
Via Benzinga
ChatGPT Stock Predictions: 3 Companies the AI Bot Thinks Have 10X Potential
Navigate the stock market with confidence using AI stock predictions. Harness the latest in AI technology for strategic investment planning. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks Down 36% or More to Buy and Hold for 10 Years
These companies have seen better days. 
Via The Motley Fool
3 Gene Editing Stocks With Unprecedented Surge Potential
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
Via Benzinga
Spotlight on Moderna: Analyzing the Surge in Options Activity
Via Benzinga
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
Via Benzinga
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly. 
Via InvestorPlace
Why Is Moderna Stock Trading Lower Today?
Moderna long term data indicates a faster decline in efficacy for its RSV vaccine than the RSV vaccines from GSK and Pfizer. 
Via Benzinga
7 Stocks to Sell as Fast as You Possibly Can
Are you willing to sacrifice your returns just to hold on to these stocks? Each of them is a stock to sell now to save your portfolio. 
Via InvestorPlace
If You Invested $10,000 in Moderna in 2019, This Is How Much You Would Have Today
Moderna generated billions of dollars in earnings from its coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine... 
Via Benzinga
1 Stock Down 43% to Buy and Hold for 10 Years
This biotech isn't just a pandemic stock. 
Via The Motley Fool
Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering
Via ACCESSWIRE
3 Doomed Nasdaq Stocks to Dump Before They Dive: February 2024
Investors would be smart to steer clear of these companies, each of which is facing problems that seem insurmountable. 
Via InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a... 
Via Benzinga
Exposures COVID-19
Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Via ACCESSWIRE
Moderna Named to Fortune's List of World's Most Admired Companies
Via ACCESSWIRE
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions. 
Via Benzinga
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
The stock is high risk, but rewards could be great if all works out well for Novavax. 
Via The Motley Fool
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
These stocks could deliver top returns now and well into the future. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts
This biotech's prospects go well beyond COVID-19. 
Via The Motley Fool
3 S&P 500 Stocks With 127% to 170% Upside in 2024, According to Select Wall Street Analysts
Wall Street's benchmark index is comprised of 500 companies, three of which could deliver triple-digit upside in the new year. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Highlights From the 2024 JPMorgan Health Care Conference
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. 
Via The Motley Fool
If You Invested $10,000 in Moderna at the End of 2019, This Is How Much You Would Have Today
Has the stock wiped out its gains since the pandemic? 
Via The Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks. 
Via The Motley Fool
Exposures COVID-19
3 Stocks Poised to Bounce Back After a Brutal 2023
These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead. 
Via InvestorPlace
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.